411 related articles for article (PubMed ID: 35173043)
1. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.
Qiu M; Tang Y; Chen J; Muriph R; Ye Z; Huang C; Evans J; Henske EP; Xu Q
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35173043
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis.
Atochina-Vasserman EN; Abramova E; James ML; Rue R; Liu AY; Ersumo NT; Guo CJ; Gow AJ; Krymskaya VP
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1447-54. PubMed ID: 26432869
[TBL] [Abstract][Full Text] [Related]
3. The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles.
Dilliard SA; Sun Y; Brown MO; Sung YC; Chatterjee S; Farbiak L; Vaidya A; Lian X; Wang X; Lemoff A; Siegwart DJ
J Control Release; 2023 Sep; 361():361-372. PubMed ID: 37536547
[TBL] [Abstract][Full Text] [Related]
4. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
[TBL] [Abstract][Full Text] [Related]
5. Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs.
Li Q; Chan C; Peterson N; Hanna RN; Alfaro A; Allen KL; Wu H; Dall'Acqua WF; Borrok MJ; Santos JL
ACS Chem Biol; 2020 Apr; 15(4):830-836. PubMed ID: 32155049
[TBL] [Abstract][Full Text] [Related]
6. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
[TBL] [Abstract][Full Text] [Related]
7. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M; Li Y; Bloomer H; Xu Q
Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
[TBL] [Abstract][Full Text] [Related]
8. Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery.
Zeng G; He Z; Yang H; Gao Z; Ge X; Liu L; Liu Z; Chen Y
ACS Appl Mater Interfaces; 2024 May; 16(20):25698-25709. PubMed ID: 38717294
[TBL] [Abstract][Full Text] [Related]
9. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.
Pardi N; Tuyishime S; Muramatsu H; Kariko K; Mui BL; Tam YK; Madden TD; Hope MJ; Weissman D
J Control Release; 2015 Nov; 217():345-51. PubMed ID: 26264835
[TBL] [Abstract][Full Text] [Related]
10. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
11. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
Francia V; Schiffelers RM; Cullis PR; Witzigmann D
Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery.
Swingle KL; Billingsley MM; Bose SK; White B; Palanki R; Dave A; Patel SK; Gong N; Hamilton AG; Alameh MG; Weissman D; Peranteau WH; Mitchell MJ
J Control Release; 2022 Jan; 341():616-633. PubMed ID: 34742747
[TBL] [Abstract][Full Text] [Related]
13. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
[TBL] [Abstract][Full Text] [Related]
15. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
[TBL] [Abstract][Full Text] [Related]
16. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
[TBL] [Abstract][Full Text] [Related]
17. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs.
Lokugamage MP; Vanover D; Beyersdorf J; Hatit MZC; Rotolo L; Echeverri ES; Peck HE; Ni H; Yoon JK; Kim Y; Santangelo PJ; Dahlman JE
Nat Biomed Eng; 2021 Sep; 5(9):1059-1068. PubMed ID: 34616046
[TBL] [Abstract][Full Text] [Related]
18. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
[TBL] [Abstract][Full Text] [Related]
20. Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells.
Tang Y; El-Chemaly S; Taveira-Dasilva A; Goldberg HJ; Bagwe S; Rosas IO; Moss J; Priolo C; Henske EP
Chest; 2019 Dec; 156(6):1137-1148. PubMed ID: 31299246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
